|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 6/25/18 CollPlant Holdings Ltd. 6-K 6/25/18 1:16K Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size 1: 6-K Report of Foreign Private Issuer HTML 11K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2018
Commission File Number 001-38370
CollPlant Holdings Ltd.
(Exact name of registrant as specified in its charter)
3 Sapir Street, Weizmann Science Park
Ness Ziona 74140, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
C:
As previously disclosed by CollPlant Holdings Ltd. (the “Company”), the Company petitioned the District Court to approve the convening of a special general meeting of its shareholders and the holders of Series I Warrants and Series K Warrants for the purpose of obtaining approval to voluntarily delist the Company’s ordinary shares from the Tel Aviv Stock Exchange, while maintaining a continued listing on NASDAQ. Subsequently, at separate meetings, the shareholders and holders of Series I Warrants and Series K Warrants approved an arrangement between the Company, its shareholders and the holders of Series I Warrants and Series K Warrants for the delisting of all of the Company’s securities from trading on the Tel Aviv Stock Exchange Ltd. pursuant to Section 350 of the Israeli Companies Law of 1999 (the “Arrangement”). On June 24, 2018, the Company submitted a request to the District Court for the approval of the Arrangement. For additional information on the Arrangement, please see the Company’s Notice of Extraordinary General Meetings of Shareholders and Holders of Series I Warrants and Series K Warrants dated May 3, 2018 and accompanying Proxy Statement attached as Exhibit 99.1 to the Company’s Form 6-K that was furnished to the U.S. Securities and Exchange Commission (the “SEC”) on May 3, 2018 and the Notice to the Shareholders, Holders of Series I Warrants and Series K Warrants Shareholders dated June 7, 2018 attached as Exhibit 99.1 to the Company’s Form 6-K that was furnished to the SEC on June 7, 2018. Any person who wishes to object to the Arrangement is required to submit his or her objection to the District Court within 10 days of June 25, 2018 (i.e., on or before July 5, 2018).
C:
| C: 1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| COLLPLANT HOLDINGS LTD. | ||
| Date: June 25, 2018 | By: | /s/ Eran Rotem |
| Name: Eran Rotem | ||
| Title: Deputy CEO and Chief Financial Officer | ||
C:
| 2 |
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 7/5/18 | ||||
| Filed on / For Period End: | 6/25/18 | |||
| 6/24/18 | ||||
| 6/7/18 | 6-K | |||
| 5/3/18 | 6-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/16/21 CollPlant Biotechnologies Ltd. 424B5 1:566K EdgarAgents LLC/FA |